Market Performance - The A-share market is experiencing a significant rise, with the Kexin New Materials ETF (589180) increasing by 2.65% [1] - Notable stocks include China Shipbuilding Gas, which hit the daily limit with a 20% increase, and Guanggang Gas, which rose over 13% [1] New Materials Industry Outlook - The new materials sector is identified as a crucial direction for the chemical industry, currently witnessing rapid downstream demand growth [3] - With policy support and technological breakthroughs, the domestic new materials industry is expected to enter an accelerated growth phase [3] Sector Focus Areas 1. **Electronic Information Sector** - Key areas of focus include semiconductor materials, display materials, and 5G materials [4] - In Q2 2025, global silicon wafer shipments reached 3,327 million square inches, a 9.6% increase year-over-year [4] 2. **Aerospace Sector** - Focus on PI films, precision ceramics, and carbon fibers [5] - The successful launch of the "Forged Star 1" satellite marks a significant milestone in space manufacturing technology [5] 3. **New Energy Sector** - Key areas include photovoltaics, lithium-ion batteries, proton exchange membranes, and hydrogen storage materials [6] 4. **Biotechnology Sector** - Focus on synthetic biology and scientific services [7] - Hainan Province is enhancing cooperation in biomedicine and high-end consumer goods manufacturing [7] 5. **Energy Conservation and Environmental Protection Sector** - Focus on adsorbent resins, membrane materials, and biodegradable plastics [8] - A new action plan for heavy metal pollution prevention has been issued, aiming for significant improvements by 2030 [8]

Core Viewpoint - The article highlights the breakthrough in the commercialization of bio-based nylon composite materials, particularly focusing on the establishment of a bio-based battery shell manufacturing base by Anhui Kaisa Times Composite Materials Co., Ltd. in collaboration with CATL, which signifies a significant advancement in the bio-based new materials industry [2][6]. Summary by Sections Project Overview - The project involves a total investment of 500 million yuan, aiming to build 18 production lines for bio-based battery shells, with an annual production capacity of 2.5 million sets [2]. - The bio-based battery shells will utilize long and short glass fiber bio-based nylon 56 composite materials, with specific thicknesses of 1.0mm for the main body and 3.0mm for the flange [2]. Company Background - Anhui Kaisa Times was established on February 12, 2025, through a collaboration between Kaisa Bio, CATL's investment platform Puchuan Capital, and Kallai Composite Materials [2]. - The company focuses on the R&D, production, and sales of bio-based composite materials for applications in battery shells, energy storage boxes, automotive parts, and other transportation sectors [2]. Product Specifications - The bio-based battery shell products have various specifications, including dimensions of 2m x 1.5m and 1.5m x 1.2m, with production capacities of 50,000 and 200,000 units per year, respectively [3]. - Quality standards for the products include impact strength of ≥80 kJ/m², precision tolerance of <0.1mm, temperature resistance from -40°C to 120°C, and insulation resistance of >100 MΩ [3]. Material and Production Capacity - The raw materials for the battery shell project are derived from a bio-based composite material project with an annual production capacity of 41,000 tons, announced in June [4]. - The production plan includes 20,000 tons/year of composite products, 3,000 tons/year of photovoltaic frame products, and 18,000 tons/year of construction template products [4][5]. Strategic Collaborations - Kaisa Bio has established strategic partnerships, including a collaboration with Fuyang Transportation Energy Investment Co., Ltd. to focus on the application of bio-based polyamide composite materials [4]. - A joint venture with South Korea's 3P.COM was also formed to develop thermoplastic bio-based polyamide composite materials for various applications, including hydrogen storage and transportation [4]. Market Position and Future Outlook - Despite currently operating at a loss, Kaisa Bio has established a complete industrial chain from monomer to resin to composite materials, with applications in multiple markets such as batteries, photovoltaics, and construction [6]. - The significant investment from China Merchants Group and a procurement agreement for 290,000 tons of bio-based polyamide are crucial for the company's growth and serve as a model for other new materials enterprises [7]. Regulatory Support - Bio-based nylon 56 has been included in the "14th Five-Year Plan" for new material industry development and is recognized in the first batch of application insurance compensation directories by the Ministry of Industry and Information Technology [10].

Core Viewpoint - The AMAC Chemical Fiber Index experienced a decline of 0.57%, closing at 3837.96 points, with a trading volume of 3.384 billion yuan, despite showing positive growth over the past month, three months, and year-to-date [1] Group 1: Index Performance - The AMAC Chemical Fiber Index has increased by 6.53% over the past month [1] - The index has risen by 9.31% over the last three months [1] - Year-to-date, the index has shown a growth of 9.89% [1] Group 2: Index Composition - The top ten holdings of the AMAC Chemical Fiber Index are: Tongkun Co., Ltd. (13.53%), Guangwei Composites (11.72%), Kaisa Biotechnology (11.33%), Huafeng Chemical (10.12%), Hengyi Petrochemical (8.51%), Zhongjian Technology (8.44%), New Fengming (6.32%), Jilin Chemical Fiber (5.23%), Taihe New Materials (4.32%), and Hailide (3.15%) [1] - The market share of the AMAC Chemical Fiber Index is composed of 60.77% from the Shenzhen Stock Exchange and 39.23% from the Shanghai Stock Exchange [1] Group 3: Industry Classification - The AMAC Chemical Fiber Index is entirely composed of the raw materials sector, with a 100% allocation [1]

Group 1 - The company plans to hold its second extraordinary general meeting of shareholders on August 18, 2025, at 14:00, using a combination of on-site and online voting methods [1] - The company will utilize the Shanghai Stock Exchange Information Network Co., Ltd. to provide a shareholder meeting reminder service, ensuring that small and medium-sized investors can participate and vote [2] - Investors will receive notifications via smart SMS about the meeting and voting proposals, and they can vote directly through the provided instructions or existing voting platforms [2] Group 2 - The company expresses gratitude to investors for their attention and support, encouraging feedback on the new service through email and investor hotlines [2]

Core Points - The Shanghai Cathay Biotech Co., Ltd. is holding its second extraordinary general meeting of shareholders in 2025 on August 18 [1][2] - The meeting aims to ensure the legal rights of all shareholders and maintain order and efficiency during the proceedings [2][3] Meeting Procedures - Shareholders must verify their identity upon arrival and sign in to confirm their attendance [2][3] - Attendees are required to return their shareholder certificates and meeting folders after the meeting [3] - Shareholders have the right to speak and vote during the meeting, but must adhere to the agenda and obtain permission from the meeting host to speak [3][5] Voting and Agenda - The network voting will take place on August 18, 2025, during specified trading hours [5] - The agenda includes the announcement of the meeting's commencement, introduction of attendees, and the review of several proposals [9] - Key proposals include the cancellation of the supervisory board and amendments to the company's articles of association [5][8] Proposals Overview - Proposal 1: Cancellation of the supervisory board and modification of the company's articles to enhance governance structure [5][6] - Proposal 2: Amendments to the company's rules for shareholder meetings and other governance documents to ensure compliance with relevant laws [8] - Proposal 3: Election of non-independent directors for the third board, with candidates nominated for a three-year term [11][12] - Proposal 4: Election of independent directors for the third board, with candidates already approved by the Shanghai Stock Exchange [11][12]

上海凯赛生物技术股份有限公司 2025 年第二次临时股东大会会议资料 证券代码：688065 证券简称：凯赛生物 上海凯赛生物技术股份有限公司 上海凯赛生物技术股份有限公司 2025 年第二次临时股东大会会议资料 上海凯赛生物技术股份有限公司 地址：中国（上海）自由贸易试验区蔡伦路 1690 号 5 幢 邮编：201203 电话：86-21-50801916 传真：86-21-50801386 网站：http://www.cathaybiotech.com 2025 年第二次临时股东大会会议资料 中国·上海 二〇二五年八月十八日 上海凯赛生物技术股份有限公司 2025 年第二次临时股东大会会议资料 目 录 | 上海凯赛生物技术股份有限公司 2025 年第二次临时股东大会会议须知 1 | | --- | | 上海凯赛生物技术股份有限公司 2025 年第二次临时股东大会议程 3 | | 议案一：关于取消公司监事会并修改公司章程的议案 4 | | 议案二：关于修改公司《股东会议事规则》等规章制度的议案 5 | | 议案三：关于选举公司第三届董事会非独立董事的议案 6 | | 议案四：关于选举公司第三届董事会独立董事 ...

为更好地服务广大中小投资者，确保有投票意愿的中小投资者能够及时参会、 及时投票，公司拟使用上证所信息网络有限公司（以下简称"上证信息"）提供 的股东大会提醒服务，委托上证信息通过智能短信等形式，根据股权登记日的股 东名册主动提醒股东参会投票，向每一位投资者主动推送股东大会参会邀请、议 案情况等信息。投资者在收到智能短信后，可根据《上市公司股东会网络投票一 键通服务用户使用手册》（下载链接：https://vote.sseinfo.com/i/yjt_help.pdf）的 提示步骤直接投票，如遇拥堵等情况，仍可通过原有的交易系统投票平台和互联 网投票平台进行投票。 若广大投资者对本次服务有任何意见或建议，可通过邮件、投资者热线等方 式向公司反馈，感谢广大投资者对公司的关注与支持。 特此公告。 证券代码：688065 证券简称：凯赛生物 公告编号：2025-040 上海凯赛生物技术股份有限公司 关于股东大会开设网络投票提示服务的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 上海凯赛生物技术股份有限公司（以下简称"公司"）拟 ...

Investment Rating - The report maintains a rating of "Outperform" for the new materials sector [1]. Core Insights - The new materials sector has experienced a decline, with the new materials index falling by 2.34%, underperforming the ChiNext index by 1.59% [2]. - The global humanoid robot market is projected to grow from $2.16 billion in 2023 to $32.4 billion by 2029, with a compound annual growth rate (CAGR) of 57% [5]. - The domestic PEEK material market is expected to reach 2.1 billion yuan by 2025, reflecting a year-on-year growth of 10.53% [5]. Market Performance - The new materials sector saw a decline this week, with the new materials index down by 2.34% [2]. - Over the past five trading days, the synthetic biology index increased by 2.06%, while semiconductor materials decreased by 0.65% and battery chemicals fell by 3.84% [18]. - The overall market performance for the new materials sector has been mixed, with various sub-sectors showing different trends [19]. Price Tracking - Amino acids such as valine, arginine, and tryptophan have seen price changes of -1.05%, -1.64%, and -2.15% respectively [3]. - Prices for biodegradable materials like PLA and PBS remained stable, while PBAT was priced at 9,850 yuan per ton [3]. - The price of industrial gases and electronic chemicals has also remained unchanged, indicating stability in these segments [3]. Investment Recommendations - The report suggests focusing on companies involved in PEEK material production and modification, such as Zhongxin Fluorine Materials and Zhongyan Co., as well as functional protective casing manufacturers like Jundida [5][6]. - The upcoming World Robot Conference is highlighted as a key event to watch for advancements in humanoid robot materials [5].

Group 1 - The company will hold its second extraordinary general meeting of shareholders in 2025 on August 18 at 14:00 in Shanghai [2][4] - The voting will be conducted through both on-site and online methods, with specific time slots for each [4][6] - Shareholders must register to attend the meeting, with detailed requirements for both individual and corporate shareholders [10][12] Group 2 - The meeting will review several proposals, including the election of the third board of directors, which will consist of 5 non-independent directors, 3 independent directors, and 1 employee representative director [24][26] - The election will utilize a cumulative voting system, allowing shareholders to allocate their votes among candidates [9][22] - The current board will continue to operate until the new board is elected [27] Group 3 - The company has initiated a share repurchase program, with a total budget between RMB 10 million and RMB 20 million, and a maximum repurchase price of RMB 67 per share [38][39] - As of July 31, 2025, the company has repurchased 230,366 shares, representing 0.0319% of the total share capital, at a total cost of approximately RMB 10.5 million [40] Group 4 - The company has decided to abolish its supervisory board, transferring its responsibilities to the audit committee of the board of directors [43] - Amendments to the company's articles of association and related internal management systems will be made accordingly [45]

Core Points - The document outlines the independent director system of Shanghai Kaisa Biotechnology Co., Ltd, aiming to enhance corporate governance and protect the interests of minority shareholders [1][2][3] Chapter Summaries Chapter 1: General Principles - The independent director system is established to improve the governance structure of the company and ensure the protection of minority shareholders' rights [1] - Independent directors must not hold any other positions within the company and should have no direct or indirect interests that could affect their independent judgment [1] Chapter 2: Qualifications for Independent Directors - Basic qualifications for independent directors include legal eligibility, independence, knowledge of company operations, and relevant work experience [2] - Candidates must not have any significant negative records in the past 36 months related to securities violations or other misconduct [2] Chapter 3: Independence of Directors - Certain individuals are prohibited from serving as independent directors, including those with significant shareholdings or familial ties to major shareholders [3][4] Chapter 4: Nomination, Election, and Replacement of Independent Directors - Independent director candidates can be proposed by the board or shareholders holding more than 1% of shares, requiring majority approval at the shareholders' meeting [5] - The company must disclose detailed information about independent director candidates before the shareholders' meeting [6][7] Chapter 5: Responsibilities and Duties of Independent Directors - Independent directors are responsible for participating in board decisions, supervising potential conflicts of interest, and providing professional advice [8][9] - They have the authority to hire external consultants for audits or inquiries into specific matters [9][10] Chapter 6: Special Meetings of Independent Directors - The company must hold regular or ad-hoc meetings exclusively for independent directors to discuss relevant issues [12][13] Chapter 7: Obligations of Independent Directors - Independent directors must maintain independence and report any conflicts of interest or issues affecting their ability to perform their duties [14][15] - They are required to keep detailed records of their activities and interactions related to their responsibilities [15][16] Chapter 8: Rights of Independent Directors and Company Obligations - The company must ensure independent directors have equal access to information and necessary resources to perform their duties [16][17] - Independent directors are entitled to reasonable compensation, which must be disclosed in the company's annual report [17] Chapter 9: Supplementary Provisions - The independent director system must comply with national laws and regulations, and any conflicts with future regulations will be resolved in favor of the latter [18][19]